ClinicalTrials.gg
CompletedNCT01522885KatGuideUpdated Aug 21, 2014

KatGuide Method Versus Conventional Method at Insertion of Chest Tube

A Phase 3 interventional study of KatGuide versus conventional method (forceps) and Chest tube insertion in Pneumothorax, Hydrothorax and Hemothorax, sponsored by Niels Katballe. Completed at 4 sites in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-08-21.

Sponsored by Niels Katballe · Phase 3, Interventional, and Treatment

Phase
Phase 3
Study type
Interventional
Enrollment
109
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to investigate whether if KatGuide (a new developed medical device) improves the placing of a large bore chest tube in the pleural cavity compared to the conventional method.

02

Conditions studied

  • Pneumothorax
  • Hydrothorax
  • Hemothorax
  • Empyema
  • Chylothorax

Keywords

  • Chest tube
  • placement
  • mal positioning
03

In context

Pneumothorax

183 studies on the registry are indexed under Pneumothorax; 41 are open to participants now.

This study's enrollment of 109 is close to the median of 100 across 111 interventional studies indexed under Pneumothorax.

Browse Pneumothorax studies →

Lead sponsor

This is the only study on the registry with Niels Katballe as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with pneumothorax in the upper pleural space or fluid in the lower pleural space.
  • Indication for upper or lower placement of a single chest tube in the pleural cavity
  • 18 years of age or older

Exclusion criteria

Exclusion Criteria:

  • Fertile women
  • Patients who can not give written or verbal consent to participate
  • If there is no time or possibility to inform the patient
  • Patients who already has a large bore chest tube
  • Patients with long lasting (>14 days) or chronic chest tube
  • Patients with both fluid and air in the pleural cavity
  • Patients where "the safe area" (front axillary fold, IC 4-5) can not be used for chest tube insertion
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
109 participants (actual)

Study arms

  • Active comparator
    KatGuide

    Chest tube insertion is performed by using the KatGuide

    Device: KatGuide versus conventional method (forceps)

  • Active comparator
    Conventional group

    Chest tubes are inserted by using conventional method (forceps) for large bore chest tube insertion.

    Procedure: Chest tube insertion

Interventions

  • DeviceKatGuide versus conventional method (forceps)

    According to randomization Chest tubes are placed in the pleural cavity by using the KatGuide device.

  • ProcedureChest tube insertion

    The chest tube is placed in the pleural cavity by using a forceps (conventional method) or KatGuide

06

What researchers measure

Primary outcomes

  1. Chest tube placement

    X-ray examination of the chest is performed within 3 hours after the chest tube insertion, to evaluate if the placement of the chest tube is acceptable.

    Time frame: 3 hours

Secondary outcomes

  1. Length of hospital stay

    The hospital stay depends on how long time it takes to solve the chest tube related problem. In a few patients it takes only one day, but in severe cases it may take weeks before the patient can be discharged. We predict, that the patient will be in hospital for a mean time of 5 days.

    Time frame: 5 days

  2. Time with chest tube

    A few patients can have the chest tube removed in only one day, but some patients must have a chest tube for weeks. We predict that the patients will have a chest tube in a mean time of 3 days.

    Time frame: 3 days (mean time)

  3. Infection in wound

    4 weeks after the chest tube insertion, the patient is contacted and the patient is asked whether there are problems with infection of the wound.

    Time frame: 4 weeks

  4. Number of chest tubes

    It is observed whether the patient has multiple chest tubes inserted in the pleural cavity at the same side. It is predicted, that these patients are hospitalized longer than patients with only one chest tube. We predict, that these patients are hospitalized for a mean time of 7 days.

    Time frame: 7 days (mean time)

07

Study locations

4 sites
  • Niels Katballe
    Aarhus, Aarhus N 8200, Denmark
  • Vytautas Nekrasas
    Aalborg, 9000, Denmark
  • Niels Katballe
    Aarhus N, 8200, Denmark
  • Peter B Licht
    Odense, 5000, Denmark
08

References and documents

Publications

  • Katballe N, Moeller LB, Olesen WH, Litzer MM, Andersen G, Nekrasas V, Licht PB, Bach P, Pilegaard HK. A Novel Device for Accurate Chest Tube Insertion: A Randomized Controlled Trial. Ann Thorac Surg. 2016 Feb;101(2):527-32. doi: 10.1016/j.athoracsur.2015.07.017. Epub 2015 Sep 26. PubMed 26409714 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 21, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01522885
Lead sponsor
Niels Katballe
Responsible party
Niels Katballe (Coordinating investigator, MD, PhD, University of Aarhus) — Sponsor-investigator
First posted
Feb 1, 2012
Start date
Apr 2012
Primary completion
May 2014
Completion
May 2014
Last update
Aug 21, 2014

Study contacts

Niels Katballe, MD, PhD
study director · University of Aarhus

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion